Integrated Analyses of the Expression and Prognostic Value of EPHB6 in Cervical Cancer and Its Correlation with Immune Infiltrates

Table 1

Correlation of clinicopathological features of CC with the expression level of EPHB6.

Characteristic	Low expression of EPHB6	High expression of EPHB6	p
n	153	153
Age, n (%)			0.127
≤50	101 (33%)	87 (28.4%)
>50	52 (17%)	66 (21.6%)
Clinical stage, n (%)			0.449
Stage I	85 (28.4%)	77 (25.8%)
Stage II	29 (9.7%)	40 (13.4%)
Stage III	25 (8.4%)	21 (7%)
Stage IV	12 (4%)	10 (3.3%)
Histologic grade, n (%)			1.000
G1	9 (3.3%)	10 (3.6%)
G2	67 (24.5%)	68 (24.8%)
G3	60 (21.9%)	59 (21.5%)
G4	0 (0%)	1 (0.4%)
Age, median (IQR)	45 (37, 55)	47 (40, 59)	0.071